Collaborate Disseminate
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, with AstraZeneca revealing “encouraging data” out of its Phase I study of its obesity and diabetes drug AZD5004.Continue ReadingC… Continue reading Weight-loss pill passes important safety trial
An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics and the elderly. The researchers behind the innovative treatment say that it’s an alternative to the current treatment: regular… Continue reading RNA therapy an effective alternative to lifelong, painful eye injections
A new continuous glucose monitor (CGM) that is not only non-invasive but that predicts blood sugar levels from ECG data promises to shake up diabetes management. The device is being showcased at the 2024 Taiwan Innotech Expo.Continue ReadingCategory: B… Continue reading Non-invasive ECG device for diabetics live-monitors your blood sugar
An insulin that switches itself on and off in response to blood glucose levels has proven successful in lowering the risk of dangerously low glucose levels, or hypos, in animals. According to researchers, the drug holds great promise for the tens of mi… Continue reading ‘Insulin with a switch’ will help diabetics avoid dangerous hypos
An insulin that switches itself on and off in response to blood glucose levels has proven successful in lowering the risk of dangerously low glucose levels, or hypos, in animals. According to researchers, the drug holds great promise for the tens of mi… Continue reading ‘Insulin with a switch’ will help diabetics avoid dangerous hypos
An insulin that switches itself on and off in response to blood glucose levels has proven successful in lowering the risk of dangerously low glucose levels, or hypos, in animals. According to researchers, the drug holds great promise for the tens of mi… Continue reading ‘Insulin with a switch’ will help diabetics avoid dangerous hypos
86% of type 2 diabetes patients treated with a new procedure no longer needed insulin throughout the two-year-long study they participated in. That procedure could be a real game changer for nearly half a billion people currently estimated to be living… Continue reading New type 2 diabetes treatment could mean an end to insulin shots
Nanosized particles that release glucagon, the hormone responsible for raising blood glucose levels, on-demand could mean that diabetics don’t need to worry about potentially dangerous low blood sugar levels, according to new research.Continue ReadingC… Continue reading Glucose-responsive nanotech prevents dangerously low blood sugar
Type 1 diabetes is an auto-immune condition whereby the patient’s own immune system attacks the pancreatic islets, destroying them in the process. Since these islets are responsible for producing insulin …read more Continue reading Reversing Type 1 Diabetes With a Patient’s Own Stem Cells
A patient with type 1 diabetes has been functionally cured of the disease, requiring no insulin doses for over a year. The treatment involves growing and transplanting new insulin-producing cells from the patient’s own stem cells.Continue ReadingCatego… Continue reading “Functional cure” for diabetes restores insulin production with stem cells